Clinical trial
Metformin And Cardiovascular Effectiveness vs SGLT2 (MACES)
NCT03627039 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Metformin And Cardiovascular Effectiveness vs SGLT2 (MACES)
- Lead sponsor
- Brigham and Women's Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- September 1, 2018
- Completion date
- August 1, 2020
- Enrollment
- 20,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.